stoxline Quote Chart Rank Option Currency Glossary
180 Life Sciences Corp. (ATNF)
0.238  -0.002 (-0.79%)    12-08 15:52
Open: 0.231
High: 0.2454
Volume: 300,940
Pre. Close: 0.2399
Low: 0.22
Market Cap: 2(M)
Technical analysis
2023-12-08 4:41:43 PM
Short term     
Mid term     
Targets 6-month :  0.44 1-year :  0.56
Resists First :  0.38 Second :  0.48
Pivot price 0.3
Supports First :  0.21 Second :  0.18
MAs MA(5) :  0.25 MA(20) :  0.32
MA(100) :  0.57 MA(250) :  1.51
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  9.9 D(3) :  9.8
RSI RSI(14): 31.1
52-week High :  8 Low :  0.21
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ATNF ] has closed above bottom band by 12.9%. Bollinger Bands are 21.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.25 - 0.25 0.25 - 0.25
Low: 0.22 - 0.22 0.22 - 0.22
Close: 0.23 - 0.24 0.24 - 0.24
Company Description

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Headline News

Mon, 04 Dec 2023
180 Life Sciences engages financial advisor to explore strategic alternatives - Seeking Alpha

Mon, 04 Dec 2023
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives - Yahoo Finance

Wed, 29 Nov 2023
180 Life Sciences : Material Agreement - Form 8-K -November 29, 2023 at 08:13 am EST -

Wed, 29 Nov 2023
Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - 180 Life Scienc - Benzinga

Sun, 12 Nov 2023
Certain Warrants of 180 Life Sciences Corp. are subject to a Lock-Up Agreement Ending on 13-NOV-2023. -

Wed, 09 Aug 2023
180 Life Sciences (NASDAQ: ATNF) up 75% - that cannabis delusion again - Dhaka Tribune

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 7 (M)
Shares Float 7 (M)
Held by Insiders 7.4 (%)
Held by Institutions 4.1 (%)
Shares Short 160 (K)
Shares Short P.Month 104 (K)
Stock Financials
EPS -14.2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.02
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -56.2 %
Return on Equity (ttm) -312.1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -2.35
Qtrly Earnings Growth 0 %
Operating Cash Flow -12 (M)
Levered Free Cash Flow -6 (M)
Stock Valuations
PE Ratio -0.02
PEG Ratio 0
Price to Book value -11.91
Price to Sales 0
Price to Cash Flow -0.16
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android